FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/08/027498 [Registered on: 31/08/2020] Trial Registered Prospectively
Last Modified On: 28/08/2020
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Impact of heavy metals on unexplained preterm birth and related death 
Scientific Title of Study   Unexplained preterm birth and related death:Does heavy metals play heavily 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Dinesh Upadhya 
Designation  Associate Professor and Coordinator 
Affiliation  Manipal Academy of Higher Education  
Address  Centre for Molecular Neurosciences Physiology block 2nd floor Kasturba Medical College Manipal Udupi Karnataka 576104

Udupi
KARNATAKA
576104
India 
Phone  8747012060  
Fax    
Email  dinesh.upadhya@manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Dinesh Upadhya 
Designation  Associate Professor and Coordinator 
Affiliation  Manipal Academy of Higher Education  
Address  Centre for Molecular Neurosciences Physiology block 2nd floor Kasturba Medical College Manipal Udupi Karnataka 576104

Udupi
KARNATAKA
576104
India 
Phone  8747012060  
Fax    
Email  dinesh.upadhya@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Dinesh Upadhya 
Designation  Associate Professor and Coordinator 
Affiliation  Manipal Academy of Higher Education  
Address  Centre for Molecular Neurosciences Physiology block 2nd floor Kasturba Medical College Manipal Udupi Karnataka 576104

Udupi
KARNATAKA
576104
India 
Phone  8747012060  
Fax    
Email  dinesh.upadhya@manipal.edu  
 
Source of Monetary or Material Support  
Intramural grant to Dr. Dinesh Upadhya given by Manipal Academy of Higher Education, Manipal 
 
Primary Sponsor  
Name  Manipal Academy of Higher Education Intramural grant 
Address  Kasturba Medical College Manipal Academy of Higher Education Madhav Nagar Manipal Udupi karnataka 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Dinesh Upadhya  Kasturba Hospital   Room No 1, 2nd floor, Physiology Block Department- Centre for Molecular Neurosciences KMC Manipal
Udupi
KARNATAKA 
8747012060

dinesh.upadhya@manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Commitee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O369||Maternal care for fetal problem, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  0.00 Day(s)
Age To  1.00 Day(s)
Gender  Both 
Details  Preterm delivered just born fetus after parental consent will be included in the study
Groups with preterm birth with known maternal cause and unknown maternal cause of the fetus born preterm will be included 
 
ExclusionCriteria 
Details  The parents who do not give consent would be excluded
The fetus who were delivered during the regular gestation period would be excluded  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The study is expected to provide essential information about the magnitude of heavy metals in the cord blood of fetus born preterm due to unexplained as well as known maternal causes.   Just born fetus(Day 0)upto 3 months for analysis.Cord blood from just born babies will be collected and analysed in the laboratory 
 
Secondary Outcome  
Outcome  TimePoints 
Effect of heavy metals in the developmental trajectories for upto one year   From birth upto one year after delivery 
 
Target Sample Size   Total Sample Size="600"
Sample Size from India="600" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/09/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NA 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
As per WHO 2019 data, globally, 15 million babies are born preterm every year and is the leading cause of death in children under the age of 5 years. India contributes one-fifth of global data with more than 3.5 million preterm birth per year (WHO, 2019). While less than 50% of the preterm birth is attributed to multiple maternal causes, more than 50% of cases are of unknown origin (Lawn et al., 2008; Blencowe et al., 2012). The risk of neonatal death due to complications of preterm birth is too high compared to term birth. Heavy metals such as mercury, cadmium, lead, arsenic, uranium, etc are well-known pollutants of the environment and could easily cross the placenta from maternal blood to reach the developing fetus (Gundacker and Hengstschläger, 2012). Heavy metals are well known to induce oxidative stress in the trophoblastic placental tissue (Singh et al., 2018). High levels of heavy metals were seen in maternal serum, resulting in multiple adverse birth outcomes (Kippler et al., 2012a, 2012b; Hu et al., 2016; Jiang et al., 2016; Yang et al., 2016; Sabra et al., 2017; Wai et al., 2017; Chen et al., 2018; Lin et al., 2018). High levels of heavy metals were also seen in maternal blood from the Indian population, resulting in adverse birth outcomes ( Awasthi et al., 2002). Heavy metals levels were seen in maternal and cord blood and placenta (Ong et al., 1993; Al saleh et al., 2011; Hu et al., 2015). We did not find any studies measuring the magnitude of multiple heavy metals in cord blood of babies born preterm.
The proposed study is a prospective cohort study containing two experimental groups. In the first group, 200 babies born preterm due to unexplained causes will be taken. In the second group, 400 babies born preterm due to known maternal causes will be taken. Both the groups include all the preterm babies (below 28 weeks, 28-32 weeks, and 33-37 weeks) born at various gestational ages. Cord blood (10 ml) will be collected in a vacutainer from the umbilical cord and placenta after birth, the blood will be collected from the placental side and not from the fetal side and will be collected only after clamping. Written informed consent will be obtained from all participating mothers. Blood collected will be allowed to clot and centrifuged at 3000rpm for 15 minutes for serum collection. Serum samples will be aliquoted until analysis for heavy metals. All the heavy metals will be measured at Thyrocare Technologies Ltd, which measures several heavy metals such as lead, mercury, arsenic, cadmium, uranium, etc through inductively coupled plasma mass spectrometry (ICP-MS) method. All the preterm babies from both groups will be assessed until one year of development using Bayley Scales of Infant Development III for cognitive, motor, social-emotional, and adaptive behavior
 
Close